Projects per year
Personal profile
Courses
Seminar
Education
B.S., Davis,Taiwan
, National Taiwan Normal University,
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Keywords
- Molecular Oncology, Cell biology, Epigenetics、Gene Regulation, Cell Metabolism
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Exploring the Intermediate State of Therapy-Induced Neuroendocrine Prostate Cancer through Dissecting the Ar Noncanonical Roles
Wang, L.-Y. (PI), Hsu, H. C. (CoPI) & Kung, H. J. (CoPI)
01/08/24 → 31/07/25
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
Ar-V7 Associated Histone Modification and Metabolic Alterations in Enzalutamide Resistant Prostate Cancer
Wang, L.-Y. (PI)
01/08/22 → 31/07/23
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
Ar-V7 Associated Histone Modification and Metabolic Alterations in Enzalutamide Resistant Prostate Cancer
Wang, L.-Y. (PI)
01/08/21 → 31/07/22
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
Ar-V7 Associated Histone Modification and Metabolic Alterations in Enzalutamide Resistant Prostate Cancer
Wang, L.-Y. (PI)
01/08/20 → 31/07/21
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
Epigenetic Regulation of Androgen Receptor Gene Transcription and Rna Splicing in Prostate Cancer
Wang, L.-Y. (PI)
01/08/19 → 31/07/20
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir
Tang, W. F., Chang, Y. H., Lin, C. C., Jheng, J. R., Hsieh, C. F., Chin, Y. F., Chang, T. Y., Lee, J. C., Liang, P. H., Lin, C. Y., Lin, G. H., Cai, J. Y., Chen, Y. L., Chen, Y. S., Tsai, S. K., Liu, P. C., Yang, C. M., Shadbahr, T., Tang, J. & Hsu, Y. L. & 9 others, , 03 04 2024, In: Antimicrobial Agents and Chemotherapy. 68, 4, p. e0095623Research output: Contribution to journal › Journal Article › peer-review
1 Scopus citations -
Selective p300 degradation via peptide PROTAC: a new therapeutic strategy for advanced prostate cancers
Wang, L. Y., 08 2024, In: EBioMedicine. 106, p. 105245 105245.Research output: Contribution to journal › Comment/debate
Open Access -
Abstract LB133: An orally bioavailable degrader targeting androgen receptor and the splice variant in castration resistant prostate cancer
Hung, C.-L., Hung, C.-L., Wang, L.-Y., Fu, C.-W., Hsu, H.-C. & Kung, H.-J., 2023.Research output: Contribution to conference › Proceeding
Open Access -
Clostridium scindens metabolites trigger prostate cancer progression through androgen receptor signaling
Bui, N. N., Li, C. Y., Wang, L. Y., Chen, Y. A., Kao, W. H., Chou, L. F., Hsieh, J. T., Lin, H. & Lai, C. H., 04 2023, In: Journal of Microbiology, Immunology and Infection. 56, 2, p. 246-256 11 p.Research output: Contribution to journal › Journal Article › peer-review
Open Access8 Scopus citations -
Evaluation and Application of Drug Resistance by Biomarkers in the Clinical Treatment of Liver Cancer
Huang, P. S., Wang, L. Y., Wang, Y. W., Tsai, M. M., Lin, T. K., Liao, C. J., Yeh, C. T. & Lin, K. H., 10 03 2023, In: Cells. 12, 6, 869.Research output: Contribution to journal › Review article › peer-review
Open Access9 Scopus citations